Are we close to generating a bioengineered human heart? Camila Hochman-Mendez weighs in on recent advances and remaining ...

His resignation will allow Yamanaka, 59, to spend more time researching induced pluripotent stem (iPS) cells, which can be reprogrammed into becoming different types of cells in the body. “ ...

In the years following Takahashi and Yamanaka's initial success in reprogramming mouse cells, multiple groups used the same strategy to generate human iPS cells, which resemble human ES cells by ...

Yamanaka's approach of genetically induced reprogramming ... Just three years later, the field has exploded, and many of the tools for iPSC production, characterization and differentiation are ...

Research into treatment using induced pluripotent stem (iPS) cells has been generating positive results one after another.

“While original Yamanaka cocktail failed completely ... “We first need to validate the technology by creating iPSC-derived mammals beyond the mouse model, particularly non-human primates.” He added, ...

Induced pluripotent stem cells, or iPS cells for short, were first achieved by a team at Kyoto University’s Institute for Frontier Medical Sciences in 2006. Yamanaka Shin’ya, one of the lead ...

Ten years have elapsed since the government gave its full policy support for the research field of regenerative medicine centered on iPS cells. In 2012, Shinya Yamanaka of Kyoto University was ...

In the year 2006, it was shown that expression of just four gene regulatory proteins (the so-called Yamanaka factors) in specialized mouse cells was sufficient to reprogram the cells into iPS cells.

Shinya Yamanaka as director of Kyoto University's CiRA. Find out the goals under the new leadership as we look at the latest research on iPS cells. In the 21st century, the field of medicine is ...

Professor Shinya Yamanaka of Kyoto University discovered in 2006 that injecting specific genes into mouse skin cells can create iPS cells similar to embryonic stem cells. For this achievement ...